Regeneron Pharmaceuticals Inc (NASDAQ:REGN)

336.93
Delayed Data
As of Jun 20
 +9.86 / +3.01%
Today’s Change
281.89
Today|||52-Week Range
543.55
-10.38%
Year-to-Date

Today’s Trading

Previous close327.07
Today’s open327.66
Day’s range327.66 - 338.48
Volume1,299,974
Average volume (3 months)902,929
Market cap$32.8B
Data as of 4:00pm ET, 06/20/2018

Growth & Valuation

Earnings growth (last year)+34.29%
Earnings growth (this year)+14.65%
Earnings growth (next 5 years)+14.28%
Revenue growth (last year)+20.82%
P/E ratio27.3
Price/Sales7.42
Price/Book5.42

Competitors

 Today’s
change
Today’s
% change
SHPGShire+3.63+2.31%
VRTXVertex Pharmaceutica...+3.13+2.03%
BAXBaxter International...-0.84-1.13%
ALXNAlexion Pharmaceutic...+2.61+2.14%
Data as of 4:00pm ET, 06/20/2018

Financials

Next reporting dateAugust 7, 2018
EPS forecast (this quarter)$4.58
Annual revenue (last year)$5.9B
Annual profit (last year)$1.2B
Net profit margin20.41%

Profile

Sector
Health Technology
Industry
Biotechnology
Co-President, Chief Executive Officer &
Director
Leonard S. Schleifer
Co-President, Director &
Chief Scientific Officer
George Damis Yancopoulos
Corporate headquarters
Tarrytown, New York

Forecasts